Prospective multi-center trial for the efficacy of ecabet sodium on the relief of dyspepsia in Korean patients with chronic gastritis

Yang Kim Hak, Ki Baik Hahm, Myung Gyu Choi, Jong Sun Rew, Sang Young Seol, Hoon-Jai Chun, Oh Young Lee, Weon Seon Hong

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Anti-peptic and anti-inflammatory actions of ecabet sodium might be beneficial in either improving gastritis or relieving dyspeptic symptoms. This study was designed to evaluate the clinical efficacy of ecabet sodium on dyspeptic symptoms and to elucidate the molecular mechanism attributable to symptom relief in patients with chronic gastritis. Two hundred and sixty eight chronic gastritis patients with persistent dyspepsia received ecabet sodium 1 g b.i.d. for 2 weeks, after which dyspeptic symptoms were reassessed with a questionnaires as before. The changes of interleukin-8 (IL-8), inducible nitric oxide synthase (iNOS), prostaglandin E2 (PGE2), and vascular endothelial growth factor (VEGF) levels in gastric juices were measured by ELISA. The changes of nitrotyrosine in gastric mucosa were measured by immunohistochemical staining. The most common dyspeptic symptom in Korean patients with chronic gastritis was epigastric soreness (76.8%), which was improved significantly after ecabet sodium treatment (81.7%, p<.001). Ecabet sodium was more effective in patients with epigastric pain than vague abdominal discomfort (p = 0.02), especially in patients with old age. Complete relief of discomfort was more highly achieved in patients with positive Helicobacter pylori than without (p = 0.01). In spite of clear tendency that the decreased levels of IL-8, iNOS, and PGE2 and increased levels of VEGF were measured in gastric juices after ecabet sodium treatment, no statistical significance was noted, which might be due to high interindividual variations. The nitrotyrosine expressions were significantly decreased after ecabet sodium treatment than before (p<0.01). In conclusion, ecabet sodium treatment was very useful for the relief of dyspeptic symptoms in chronic gastritis, to which both attenuated inflammatory and enhanced regenerative mechanisms were contributive.

Original languageEnglish
Pages (from-to)160-168
Number of pages9
JournalJournal of Clinical Biochemistry and Nutrition
Volume41
Issue number3
DOIs
Publication statusPublished - 2007 Nov 1

Fingerprint

Dyspepsia
Gastritis
Gastric Juice
Nitric Oxide Synthase Type II
Interleukin-8
Dinoprostone
Vascular Endothelial Growth Factor A
ecabet
Therapeutics
Gastric Mucosa
Helicobacter pylori
Abdominal Pain
Digestion
Anti-Inflammatory Agents
Enzyme-Linked Immunosorbent Assay
Staining and Labeling

Keywords

  • Chronic gastritis
  • Dyspepsia
  • Ecabet sodium
  • Helicobacter pylori

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Clinical Biochemistry

Cite this

Prospective multi-center trial for the efficacy of ecabet sodium on the relief of dyspepsia in Korean patients with chronic gastritis. / Hak, Yang Kim; Hahm, Ki Baik; Choi, Myung Gyu; Rew, Jong Sun; Seol, Sang Young; Chun, Hoon-Jai; Lee, Oh Young; Hong, Weon Seon.

In: Journal of Clinical Biochemistry and Nutrition, Vol. 41, No. 3, 01.11.2007, p. 160-168.

Research output: Contribution to journalArticle

Hak, Yang Kim ; Hahm, Ki Baik ; Choi, Myung Gyu ; Rew, Jong Sun ; Seol, Sang Young ; Chun, Hoon-Jai ; Lee, Oh Young ; Hong, Weon Seon. / Prospective multi-center trial for the efficacy of ecabet sodium on the relief of dyspepsia in Korean patients with chronic gastritis. In: Journal of Clinical Biochemistry and Nutrition. 2007 ; Vol. 41, No. 3. pp. 160-168.
@article{45bb945eebfd4647900bdab40aa1e4de,
title = "Prospective multi-center trial for the efficacy of ecabet sodium on the relief of dyspepsia in Korean patients with chronic gastritis",
abstract = "Anti-peptic and anti-inflammatory actions of ecabet sodium might be beneficial in either improving gastritis or relieving dyspeptic symptoms. This study was designed to evaluate the clinical efficacy of ecabet sodium on dyspeptic symptoms and to elucidate the molecular mechanism attributable to symptom relief in patients with chronic gastritis. Two hundred and sixty eight chronic gastritis patients with persistent dyspepsia received ecabet sodium 1 g b.i.d. for 2 weeks, after which dyspeptic symptoms were reassessed with a questionnaires as before. The changes of interleukin-8 (IL-8), inducible nitric oxide synthase (iNOS), prostaglandin E2 (PGE2), and vascular endothelial growth factor (VEGF) levels in gastric juices were measured by ELISA. The changes of nitrotyrosine in gastric mucosa were measured by immunohistochemical staining. The most common dyspeptic symptom in Korean patients with chronic gastritis was epigastric soreness (76.8{\%}), which was improved significantly after ecabet sodium treatment (81.7{\%}, p<.001). Ecabet sodium was more effective in patients with epigastric pain than vague abdominal discomfort (p = 0.02), especially in patients with old age. Complete relief of discomfort was more highly achieved in patients with positive Helicobacter pylori than without (p = 0.01). In spite of clear tendency that the decreased levels of IL-8, iNOS, and PGE2 and increased levels of VEGF were measured in gastric juices after ecabet sodium treatment, no statistical significance was noted, which might be due to high interindividual variations. The nitrotyrosine expressions were significantly decreased after ecabet sodium treatment than before (p<0.01). In conclusion, ecabet sodium treatment was very useful for the relief of dyspeptic symptoms in chronic gastritis, to which both attenuated inflammatory and enhanced regenerative mechanisms were contributive.",
keywords = "Chronic gastritis, Dyspepsia, Ecabet sodium, Helicobacter pylori",
author = "Hak, {Yang Kim} and Hahm, {Ki Baik} and Choi, {Myung Gyu} and Rew, {Jong Sun} and Seol, {Sang Young} and Hoon-Jai Chun and Lee, {Oh Young} and Hong, {Weon Seon}",
year = "2007",
month = "11",
day = "1",
doi = "10.3164/jcbn.2007022",
language = "English",
volume = "41",
pages = "160--168",
journal = "Journal of Clinical Biochemistry and Nutrition",
issn = "0912-0009",
publisher = "The Society for Free Radical Research Japan",
number = "3",

}

TY - JOUR

T1 - Prospective multi-center trial for the efficacy of ecabet sodium on the relief of dyspepsia in Korean patients with chronic gastritis

AU - Hak, Yang Kim

AU - Hahm, Ki Baik

AU - Choi, Myung Gyu

AU - Rew, Jong Sun

AU - Seol, Sang Young

AU - Chun, Hoon-Jai

AU - Lee, Oh Young

AU - Hong, Weon Seon

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Anti-peptic and anti-inflammatory actions of ecabet sodium might be beneficial in either improving gastritis or relieving dyspeptic symptoms. This study was designed to evaluate the clinical efficacy of ecabet sodium on dyspeptic symptoms and to elucidate the molecular mechanism attributable to symptom relief in patients with chronic gastritis. Two hundred and sixty eight chronic gastritis patients with persistent dyspepsia received ecabet sodium 1 g b.i.d. for 2 weeks, after which dyspeptic symptoms were reassessed with a questionnaires as before. The changes of interleukin-8 (IL-8), inducible nitric oxide synthase (iNOS), prostaglandin E2 (PGE2), and vascular endothelial growth factor (VEGF) levels in gastric juices were measured by ELISA. The changes of nitrotyrosine in gastric mucosa were measured by immunohistochemical staining. The most common dyspeptic symptom in Korean patients with chronic gastritis was epigastric soreness (76.8%), which was improved significantly after ecabet sodium treatment (81.7%, p<.001). Ecabet sodium was more effective in patients with epigastric pain than vague abdominal discomfort (p = 0.02), especially in patients with old age. Complete relief of discomfort was more highly achieved in patients with positive Helicobacter pylori than without (p = 0.01). In spite of clear tendency that the decreased levels of IL-8, iNOS, and PGE2 and increased levels of VEGF were measured in gastric juices after ecabet sodium treatment, no statistical significance was noted, which might be due to high interindividual variations. The nitrotyrosine expressions were significantly decreased after ecabet sodium treatment than before (p<0.01). In conclusion, ecabet sodium treatment was very useful for the relief of dyspeptic symptoms in chronic gastritis, to which both attenuated inflammatory and enhanced regenerative mechanisms were contributive.

AB - Anti-peptic and anti-inflammatory actions of ecabet sodium might be beneficial in either improving gastritis or relieving dyspeptic symptoms. This study was designed to evaluate the clinical efficacy of ecabet sodium on dyspeptic symptoms and to elucidate the molecular mechanism attributable to symptom relief in patients with chronic gastritis. Two hundred and sixty eight chronic gastritis patients with persistent dyspepsia received ecabet sodium 1 g b.i.d. for 2 weeks, after which dyspeptic symptoms were reassessed with a questionnaires as before. The changes of interleukin-8 (IL-8), inducible nitric oxide synthase (iNOS), prostaglandin E2 (PGE2), and vascular endothelial growth factor (VEGF) levels in gastric juices were measured by ELISA. The changes of nitrotyrosine in gastric mucosa were measured by immunohistochemical staining. The most common dyspeptic symptom in Korean patients with chronic gastritis was epigastric soreness (76.8%), which was improved significantly after ecabet sodium treatment (81.7%, p<.001). Ecabet sodium was more effective in patients with epigastric pain than vague abdominal discomfort (p = 0.02), especially in patients with old age. Complete relief of discomfort was more highly achieved in patients with positive Helicobacter pylori than without (p = 0.01). In spite of clear tendency that the decreased levels of IL-8, iNOS, and PGE2 and increased levels of VEGF were measured in gastric juices after ecabet sodium treatment, no statistical significance was noted, which might be due to high interindividual variations. The nitrotyrosine expressions were significantly decreased after ecabet sodium treatment than before (p<0.01). In conclusion, ecabet sodium treatment was very useful for the relief of dyspeptic symptoms in chronic gastritis, to which both attenuated inflammatory and enhanced regenerative mechanisms were contributive.

KW - Chronic gastritis

KW - Dyspepsia

KW - Ecabet sodium

KW - Helicobacter pylori

UR - http://www.scopus.com/inward/record.url?scp=36849088978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849088978&partnerID=8YFLogxK

U2 - 10.3164/jcbn.2007022

DO - 10.3164/jcbn.2007022

M3 - Article

VL - 41

SP - 160

EP - 168

JO - Journal of Clinical Biochemistry and Nutrition

JF - Journal of Clinical Biochemistry and Nutrition

SN - 0912-0009

IS - 3

ER -